제약 바이오 기업의 기술혁신역량이 경영성과 및 기업가치에 미치는 영향

다국어 초록 (Multilingual Abstract)

In this study, the technology innovation capacity of the Pharmaceutical-bio industry was derived through previous research, and the effect of this technology innovation capacity on management performance and firm value was analyzed. The Pharmaceutical-bio industry is a next-generation flagship industry, and active efforts are being made for research and development and technology innovation worldwide.
New medicine development is characterized by complex R&D over a long period of time compared to other industries everage. Until now, various studies have been conducted to explain the characteristics of the Pharmaceutical-bio industry, but research on the technology innovation capability of the Pharmaceutical-bio industry is still lacking.
In this study, the main factors of technology innovation capacity of the Pharmaceutical-bio industry were derived and the impact of these factors on management performance and firm value was studied using multiple regression analysis. The research results are as follows.
First, this study confirmed that the amount of knowledge assets of Pharmaceutical-bio firms had a positive (+) effect on operating profit and sales. However, R&D investment did not produce significant results on operating profit and sales. Second, the amount of knowledge assets and R&D investment of Pharmaceutical-bio firms had a positive (+) effect on their firm value.
The results of this study are presumed to be influenced by the nature of the industry, in which R&D activities of domestic pharmaceutical bio companies focus on the development of new medicine and generic drugs rather than the development of new medicine, and the time lag analysis period of 3 years conducted in this paper.

목차 (Table of Contents)

• Ⅰ. 서 론 1
• 1. 연구배경 1
• 2. 연구 목적 2
• 3. 연구 범위 및 구성 3
• Ⅱ. 이론적 배경 5
• 1. 제약 바이오산업 5
• 2. 기술혁신역량 7
• 3. 경영성과 10
• 4. 기업가치 12
• Ⅲ. 연구모형 및 가설 15
• Ⅳ. 연구 방법 17
• 1. 자료수집 17
• 2. 변수의 조작적 정의 17
• 3. 자료분석방법 19
• Ⅴ. 실증분석결과 20
• 1. 기술통계량 20
• 2. 상관관계분석 23
• 3. 다중회귀분석 25
• (1) 제약 바이오기업의 기술혁신역량이 경영성과에 미치는 영향 25
• (2) 제약 바이오기업의 기술혁신역량이 기업가치에 미치는 영향 33
• Ⅵ. 결 론 37
• 1. 연구결과 요약 37
• 2. 연구의 시사점 40
• 3. 연구의 한계 및 제언 41
• 참고문헌 42